Allied Market Research

2025

Fully Integrated Covid-19 Nucleic Acid Detection Chip Market

Fully Integrated COVID-19 Nucleic Acid Detection Chip Market, by Technology (Real-Time PCR, Isothermal Nucleic Acid Amplification, Transcriptase PCR), by End-User (Clinical Diagnostics and Research Centers, Hospital Laboratories and Academic Institutes) and, by Product (Reagents and Kits, Instruments and Devices): Opportunity Analysis and Industry Forecast, 2023-2032

SE : Other

Select an option
Author's: | Sonia Mutreja
Publish Date:

Get Sample to Email

The global Fully integrated covid-19 nucleic acid detection chip market report covers market size, share, and growth rate (CAGR %) for various segments at regional and country levels. Along with various market dynamics such as drivers, restraints, market trends, and opportunities, the market overview section of the report highlights the qualitative aspect of the market. Furthermore, the section covers the market snapshot and key findings, in terms of investment opportunity and market overview. The report further includes a detailed competitive landscape comprising comprehensive profiles of leading players. The top players are assessed depending on their revenue size, market share, geographical presence, recent developments & strategic initiatives, and overall contribution to the market.

Key players identified in this report are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, Hoffman-La Roche, Qiagen, Meridian Bioscience, Biofire Diagnostics, Bioflux, Helena Laboratories, Enzo Life Sciences

Market Snapshot

Report Metric

Details

Market size available for the years

2032

Base year considered

2023

Forecast period

2024

Forecast unit

Value (USD)

Segments covered

by technology, by end-user, by product

Companies covered

Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, Hoffman-La Roche, Qiagen, Meridian Bioscience, Biofire Diagnostics, Bioflux, Helena Laboratories, Enzo Life Sciences

Key Inclusions

  • Qualitative as well as quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

  • Analysis at regional and country level, which highlights the consumption of the product or service in the different geographies.

  • Extensive company profiles section, which includes different pointers such as company overview, key executive, company snapshot, business performance, product/service portfolio, R&D spending, and key strategies and developments of the major market players.

  • The current and estimated market outlook of the Fully integrated covid-19 nucleic acid detection chip market with respect to recent developments which include analysis of drivers, market trends, and growth opportunities

  • Free 20% customization and post-sales support

Fully Integrated COVID-19 Nucleic Acid Detection Chip Market, by Technology Report Highlights

Aspects Details
icon_5
By Technology
  • Real-Time PCR
  • Isothermal Nucleic Acid Amplification
  • Transcriptase PCR
icon_6
By End-User
  • Clinical Diagnostics and Research Centers
  • Hospital Laboratories and Academic Institutes
icon_7
By Product
  • Reagents and Kits
  • Instruments and Devices
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_9
Key Market Players

Meridian Bioscience, Hoffman-La Roche, Enzo Life Sciences, Bio-Rad Laboratories, Biofire Diagnostics, Agilent Technologies, Helena Laboratories, Bioflux, Thermo Fisher Scientific Inc., Qiagen

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Fully Integrated COVID-19 Nucleic Acid Detection Chip Market, by Technology

Opportunity Analysis and Industry Forecast, 2023-2032